Studies on Labisia pumila var. alata extract with phytoestrogenic effects: impact on biological activities and gene expression by Mansor, Fazliana
From 
the Department of Molecular Medicine and Surgery, 
Karolinska Institutet, Stockholm, Sweden 
 
 
 
 
 
Studies on Labisia pumila var. alata extract with 
phytoestrogenic effects: 
 
impact on biological activities and gene expression 
 
 
 
 
 
 
Fazliana Mansor 
 
 
 
Stockholm 2010 
 SUPERVISORS 
 
Professor Claes-Göran Östenson 
Department of Molecular Medicine and Surgery 
Karolinska Institutet, Stockholm, Sweden 
 
Docent Harvest F. Gu 
Department of Molecular Medicine and Surgery 
Karolinska Institutet, Stockholm, Sweden 
 
Professor Annelie Brauner 
Department of Microbiology, Tumour and Cell Biology 
Karolinska Institutet, Stockholm, Sweden 
 
Dr Wan Nazaimoon Wan Mohamud 
Cardiovascular, Diabetes and Nutrition Research Center 
Institute for Medical Research, Kuala Lumpur, Malaysia 
 
FACULTY OPPONENT 
Docent Björn Zethelius 
Department of Public Health and Caring Sciences 
Uppsala University, Uppsala, Sweden 
 
EXAMINATION BOARD 
Professor Rachel Fisher 
Department of Medicine 
Karolinska Institutet, Stockholm, Sweden 
 
Professor Angelica Lindén Hirschberg 
Department of Women and Children’s Health 
Karolinska Institutet, Stockholm, Sweden 
 
Professor Ulf Eriksson 
Department of Medical Cell Biology 
Uppsala University, Uppsala, Sweden 
 
 
 
 
 
 
All previously published papers were reproduced with permission from the publishers. 
Published by Karolinska Institutet. Printed by Universitetsservice US-AB 
Cover picture: Fazliana Mansor, photography 
Labisia pumila var. alata. From Herbal Garden, Herbal Medicine Research Centre, 
Institute for Medical Research, Kuala Lumpur, Malaysia.  
 
© Fazliana Mansor, 2010 
ISBN 978-91-7457-094-6 
                                                                                                                                 iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my family with LOVE 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                 i 
ABSTRACT 
In Malaysia, Labisia pumila var. alata (LPva) has been used by women for generations. 
Traditionally, the plant is boiled, either alone or in decoction with other herbs. It is 
claimed to have health benefits such as to contract the uterus after childbirth, allay painful 
menstruation and irregular periods and to generally alleviate fatigue. Therefore, we aimed 
to investigate the scientific basis of LPva phytoestrogenic activities in different animal 
models and cell lines.  
In Paper I, we investigated the effects of a standardized water extract of LPva (10, 20 and 
50 mg/kg body weight/day) and compared to estrogen replacement (ERT), on body weight 
gain, uterus weight, adipose tissue mRNA and protein levels of adipokines in 
ovariectomized (OVX) female Sprague-Dawley rats. After a month of oral treatment, 
ERT- and LPva-treated OVX rats showed significantly less weight gain compared to 
untreated OVX rats. Ovariectomy caused plasma leptin levels to decrease significantly but 
when treated with LPva or ERT, plasma leptin and mRNA levels increased to levels 
higher or comparable to that seen in the sham operated control rats (SHAM). In contrast, 
the elevated plasma resistin concentrations in OVX rats were significantly reduced in rats 
given ERT and LPva extracts. The uterus to body weight ratio of untreated OVX rats was 
significantly low compared to SHAM, but showed dose-dependent increase upon 
treatment with LPva. The study provides evidence that LPva exerts uterotrophic effect and 
regulates body weight gain. 
In Paper II, we evaluated the effects of LPva on 11beta-hydroxysteroid dehydrogenase 
type 1 (Hsd11b1) and corticosterone (CORT) expressions in OVX rats. Hsd11b1 was 
chosen because it was highly expressed in a microarray analysis of OVX rat liver 
compared to SHAM. Using samples from Paper I, Hsd11b1 expressions were measured 
and found that mRNA levels in liver of OVX rats were significantly increased when 
compared to SHAM and restored to normal level after treatment with LPva or ERT. In 
adipose tissues, the Hsd11b1 mRNA level of OVX group was increased by 55 % in 
comparison to SHAM, normalized in LPva. Protein levels of 11β-HSD1 were down-
regulated in both liver and adipose tissue of LPva- and ERT-treated rats, in comparison to 
OVX rats. CORT levels in OVX group increased significantly compared to SHAM. The 
results showed that the treatment with LPva normalized Hsd11b1 mRNA expression and 
11β-HSD1 levels in OVX rats, in parallel with decreased CORT levels. Thus, LPva is 
useful for postmenopausal treatment based upon its regulation at body weight partially via 
inhibition of Hsd11b1 expression in adipose tissue and liver.  
In Paper III, we investigated the effect of LPva on body composition and metabolic 
features in a rat model of polycystic ovary syndrome (PCOS). LPva (50 mg/kg body 
weight daily) increased uterine weight (27%) and insulin sensitivity (36%) measured by 
euglycemic hyperinsulinemic clamp compared to control PCOS rats. Lipid profile was 
improved in LPva rats and plasma resistin levels were increased. In adipose tissue, LPva 
decreased leptin mRNA expression but did not affect expression of resistin and 
adiponectin. No effects on body composition, adipocyte size or plasma leptin levels were 
observed. Therefore, in this study, LPva increases uterine weight, indicating estrogenic 
effects, and improves insulin sensitivity and lipid profile in PCOS rats without affecting 
body composition. 
In Paper IV, the effects of LPva treatment on urinary tract infection (UTI) were 
investigated in an infection model using uropathogenic Escherichia coli  (UPEC)  strain 
CFT073 and the bladder epithelial cell line, T24. Our results demonstrate that LPva 
treatment induced apoptosis and significantly reduced the number of intracellular E.coli in 
bladder epithelial cells. LPva-induced apoptosis was coupled with up-regulated expression 
of pro-apoptotic caveolin-1. LPva treatment down-regulated the expression of β1 integrin 
as indicated by reduced levels of gene specific mRNA. However, LPva did not exhibit 
direct antimicrobial properties and did not influence antimicrobial peptide levels in cells. 
These findings suggest that LPva facilitates the exfoliation of infected bladder cells and 
may thereby mediate beneficial effects during UTI. 
Key words: Labisia pumila, ovariectomy, PCOS, adipokines, apoptosis 
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1. BACKGROUND 
1.1 Introduction to Malaysian traditional medicine 
In contrast to the two well-developed systems of traditional medicine found in 
Indian Ayurvedic and Chinese traditional medicine, which have been extensively 
documented over centuries (Newman 2000), there is very little documentation for 
Malaysian traditional medicine. Most literature on medicinal plant use in Malaysia 
has emerged only in the last century. Books on Malay medicine featuring herbal 
ingredients were written in the 1880s in traditional Jawi script, thus were available 
only to educated Malays of the time (Foster 2009). An 1886 script by Munshi 
Ismail was translated by John Dermont Gimlette, an English physician, and IH 
Burkill, then director of the Singapore Botanic Gardens, as The Medical Book of 
Malayan Medicine (Gimlette and Burkill 1930). Later, A Dictionary of Economic 
Products of the Malay Peninsula was written by Burkill (1935), a reference that still 
serves as the most comprehensive work on the Malay herbal, economic and 
medicinal plants (Foster 2009). 
1.2 Labisia pumila var. alata (LPva) 
 
 
 
 
 
Figure 1. Labisia pumila (a synonym latin name also known as L.pothoina). From 
Malaysian Herbal Monograph (Volume 1) (1999). Zhari Ismail, Noorhayati Ismail, 
Jaafar Lassa (contributors). Malaysian Monograph Committee. Kuala Lumpur 
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Labisia pumila or locally known as Kacip Fatimah in Malaysia, is a very popular 
herb amongst the Malaysia womenfolk. It is believed to be used for centuries but 
only documented in the early 20th century. From the family of Myrinaceae, it is a 
subherbaceous plant and exist in three varieties, namely, L. pumila var. alata 
(LPva), L. pumila var. pumila and L. pumila var. lanceolata (Stone 1988). Each 
variety commands different uses and thus, it is important  to ensure that the right 
variety is used in each case. Water extract of the plant LPva is traditionally 
consumed by Malay women as a herbal medicine to treat menstrual irregularities, 
painful menstruations and to help contracting the birth channel after delivery and 
also for “sickness in the bones” (Burkill 1935, Zakaria and Mohd 1994). Used 
regularly, it is believed to help promote overall well-being, sexual health and 
vitality (Bodeker 2009). Today, the herb, or formulations with other herbs, is 
readily available in powders or extracts in pills, capsules, mixtures with coffee or 
tea, and as a canned beverage (Foster 2009).  In addition, the family of Myrinaceae 
has a notable use for the treatment of uterine disorders. It was reported that another 
Malaysian plant from the same genus, Ardisia lanceolata, is being used for 
postpartum protective remedy (Wiart 2006). This possibly explains that similar 
compounds which exert these effects could be found in LPva too. The LPva extract 
is used widely as a traditional medicine and warrants further investigation on 
scientific basis. Although this plant has not been subjected to a detailed 
pharmacological investigation, some biological activities have recently been 
documented.  The water extract of LPva has been found to inhibit estradiol binding 
to antibodies raised against estradiol, suggesting the presence of estrogen-like 
compounds in the extract (Husniza et al. 2000).  It has been found that LPva 
increases thickness of endometrial wall, numbers and perimeter of endometrial 
glands in rats (Effendy et al. 2004). Ayida Al-Wahaibi et al. (2008) reported that 
treatment with water extract of LPva maintained the elastic lamellae architecture of 
the ovariectomized (OVX) rat aortae in a manner comparable to that of the normal 
rats. This implied a possible role for LPva in modulating postmenopausal 
cardiovascular risks. There is also a possible mechanism for LPva in modulating 
postmenopause adiposity in a manner similar to that reported for estrogen through 
the initiation of lipolysis in adipose tissue and with a possible effect on weight 
management (Ayida Al-Wahaibi et al. 2007).  In another study, an aqueous extract 
of the plant was shown to decrease corticosterone levels with no effect on the 
immune status of pregnant rats (Pandey et al. 2008).  
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1.3 Components in LPva 
In leaves, anti-oxidant activities are found more in LPva than in the other variety, 
L. pumila var. pumila. Some components discovered in water extracts are 
flavanoids, ascorbic acid, beta-carotene, anthocyanin and phenolic content 
(Norhaiza et al. 2009). Chemical and spectroscopic methods reveal a multi-class of 
natural products belonging to phenolic compounds containing long chains, 
glycerogalactolipid, cerebrosides, alpha-tocopherol, sterols and lipids in the 
methanolic extract of LPva (Ali et al. 2009). LPva also contains triterpene saponins, 
including the compound ardisiacrispin A, which is reported in Ardisia crispa for its 
utero contracting activities (Jansakul et al. 1987, Avula et al. 2010). This possibly 
explains the phytoestrogenic activity of LPva. A further analysis by Direct Analysis 
in Real Time (DART™) showed that LPva contains gallic acid, which is a 
hypoglaecemic agent (Wan Nazaimoon WM, personal communication, July 2010). 
Interestingly, with advanced research, the potential uses are explored even more. 
LPva markedly inhibited TNF-alpha production and cyclooxygenase-2 expression. 
Decreased collagen synthesis of human fibroblasts by ultra-violet B was restored 
back to normal level after treatment with LPva extract since decreased collagen 
synthesis is one of the major causes of wrinkle formation in the skin (Fisher et al. 
1997). These results collectively suggest LPva extract has tremendous potential as 
an anti-photoaging cosmetic ingredient (Choi et al. 2010). In a different study, it 
has been shown that ethyl acetate fraction of LPva has T helper1 upregulating 
activity and suggests its possible usefulness as a therapeutic agent in immune 
compromised patients (Pandey et al. 2010). 
 
1.4 Dosage and safety 
In our studies (Papers I, II and III), the rationale for the LPva doses used was 
based on an earlier study which showed that when given at a dose of 17.5 
mg/kg/day, LPva resulted in body weight loss and lipolysis of adipose tissue in 
OVX Sprague-Dawley rats (Ayida  Al-Wahaibi et al. 2007). We therefore chose the 
three concentrations, 10, 20 and 50 mg/kg/body weight, to further evaluate the 
effects. The concentrations used were also proven to be safe, since 50 mg/kg had 
no adverse effect (Singh et al. 2009). In higher concentrations as used in another 
study, rats given 100, 700 or 2000 mg/kg rat body weight did not suffer genotoxic 
effect (Zaizuhana et al. 2006). Findings in a study suggested that aqueous extracts 
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of LPva up to 800 mg/kg/day did not show any significant reproductive toxicity or 
complication in pregnancy and delivery in rats (Wan Ezumi et al. 2007). LPva is 
generally considered safe for human consumption when used in the form of a 
traditional decoction. A pilot study on post-menopausal women indicated dosages 
of up to 560 mg/day as safe for consumption (Hazlina et al. 2009).  On the other 
hand, a study by Effendy et al. (2006) found that LPva had toxic effects on kidney 
and liver of rats. However, this study used high doses injected subcutaneously over 
a short period of time in a petroleum ether extraction, which is a very different 
preparation and therefore would yield a set of different compounds than those 
found in traditional and conventional products using water as the extraction 
solvent. These purely experimental results therefore have no relevance to real-
world usage, where solely water decoctions are used in human. However, further 
investigations on pharmacokinetics and side effects of LPva consumption should be 
carried out. 
 
1.5 Phytoestrogens 
 
Phytoestrogens belong to a large family of plant derived molecules possessing 
various degrees of estrogen like activity. The majority of phytoestrogens are 
introduced into the diet as inactive compounds. After the consumption of plant 
lignans and isoflavones, a complex enzymatic conversion occurs in the 
gastrointestinal tract resulting in the formation of compounds with a steroidal 
structure  similar to estrogens (Albertazzi and Purdie 2002). Dietary phytoestrogens 
are being promoted as alternatives to synthetic estrogens for hormone therapy, 
particularly after a few trials revealing that hormone therapy may induce increased 
risk of breast cancer (Beral et al. 2002, Chlebowski et al. 2003).  Phytoestrogens 
have been associated with a decreased risk of breast cancer  (Adlercreutz 1990, 
Messina et al. 1994) and in some studies have been shown to reduce the elevated 
gonadotropin levels associated with menopause in women (Wilcox et al. 1990, 
Cassidy et al. 1994). Despite their widespread use and increasing acceptance, the 
data on the estrogenic actions of phytoestrogens in women are confounded by 
many factors including the different doses used, the presence of endogenous 
estrogens, ages of the subjects, and the treatment regimes used (Ososki and 
Kennelly 2003). 
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1.6 Animal models 
 
1.6.2 Menopause and ovariectomized rat model (Papers I and II) 
Menopause occurs naturally when the ovary ceases folliculogenesis or artificially 
by surgical and/or medical ablation of the ovarian function (Wang et al. 2007). It is 
a hypo-estrogenic state, which may adversely affect estrogen target tissues 
(Harman 2006). Menopause, which is characterized by a reduction of estrogen 
production, is followed by a rise in the incidence of hypertension, a shift in body-
fat distribution toward a more central or male-type distribution and an aggravation 
of the lipoprotein profile, leading to metabolic syndrome and subsequently a rise in 
the incidence in cardiovascular disease (Tremollieres et al. 1999, Tchernof and 
Poehlman 2000, Seed and Knopp 2004, Carr 2003, Kannel and Wilson 1995). This 
has led to the assumption that endogenous estrogens may have a protective role in 
the development of central obesity and the metabolic syndrome. This is supported 
by the fact that postmenopausal hormone replacement therapy is capable of 
reducing the effects of menopause on fat redistribution as well as on some of the 
major cardiovascular risk factors, including the worsening of the lipoprotein profile 
and blood pressure and a reduction of the incidence of type 2 diabetes in women 
with known ischemic heart disease (Kannel and Wilson 1995, Tchernof et al. 2000, 
Seed and Knopp 2004, Harrison-Bernard and Raij 2000, Kanaya et al. 2003). 
 
 OVX rodents are traditionally used as a model for menopausal women as they 
mimic estrogen insufficiency and show a progressive increase in body weight 
(Chen and Heiman 2001, Clegg et al. 2006, Kalra et al. 1996). Withdrawal of 
estrogen with OVX increases food intake and decreases motor activity, a 
phenomenon which occurs in rodents (Lindén et al. 1990, Shimomura et al. 2002) 
and humans (Kalra et al. 1996, Wade and Schneider 1992).  Furthermore, in OVX 
rats, uterine weight is decreased and this effect is attenuated by estrogen 
administration (Rachoń et al. 2007). Therefore, OVX rats are often used to study 
the pathogenesis of increasing adiposity in human after menopause and have been 
used as human menopause clinical model to test the function of hormones and 
various drugs.  
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In a different aspect, ovariectomy-induced osteopenia in the rat produces skeletal 
responses similar to that in a post-menopausal woman. In the OVX rat, high bone 
turnover and subsequent bone loss, like in the human post-menopausal condition, 
can be prevented by estrogen replacement. Because of the striking resemblance of 
skeletal responses in humans and rats in the state of estrogen deficiency, the OVX 
rat is considered to be a gold standard model for evaluating drugs for prevention 
and reversal of osteoporosis (Kharode et al. 2008). 
 
Since the OVX model effectively demonstrated the response of known agents such 
as conjugated equine estrogen in a fashion similar to that in postmenopausal 
women (Engler-Chiurazzi et al. 2009), the OVX rat model has been an animal 
model of choice for evaluation of LPva in our study. 
 
1.6.2 Polycystic Ovary Syndrome rat model (Papers III)  
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and 
metabolic disorders, affecting approximately 5–10% of women in reproductive age. 
It is a complex endocrine and metabolic disorder associated with ovulatory 
dysfunction, hyperandrogenism, polycystic ovaries, insulin resistance, abdominal 
fat and obesity (Ehrmann 2005, Balen et al. 1995, Azziz 2004, Barber 2006, 
Hirchberg, 2009).  
 
The etiology of PCOS is unclear. One hypothesis is that PCOS is a genetically 
determined ovarian disorder in which excessive androgen production early in life 
may provide a hormonal insult that leads to PCOS in adulthood (Apter 1998, 
Crosignani and Nicolosi 2001, Franks et al 2006). Its management is often 
unsatisfactory or requires a diversified approach. The heterogeneity of PCOS is 
reflected by the existence of several animal models. A rat model has been 
developed that exhibits both ovarian and metabolic disturbances similar to human 
PCOS in which continuous exposure to nonaromatizable dihydrotestosterone 
(DHT), starting before puberty, results in polycystic ovarian morphology, adiposity 
and enlarged adipocytes, as well as insulin resistance (Mannerås et al. 2007). 
Female rats received the nonaromatizable DHT by continuous administration, 
beginning before puberty, to activate androgen receptors. Adult DHT rats had 
irregular cycles, polycystic ovaries characterized by cysts formed from atretic 
follicles and a diminished granulosa layer. They also displayed metabolic features, 
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including increased body weight, increased body fat and enlarged mesenteric 
adipocytes, as well as elevated leptin levels and insulin resistance.  
 
In women with PCOS, insulin sensitivity is decreased by 35–40%, independently of 
obesity, although obesity further exacerbates insulin resistance (Dunaif and Thomas 
2001), and an association between androgen and insulin levels has been suggested 
(Morin-Papunen et al. 2000). DHT induced insulin resistance and increased 
abdominal fat mass and adipocyte size, as in women with PCOS and 
hyperandrogenemia (Dunaif and Thomas 2001); both are independently associated 
with insulin resistance and prediction of type 2 diabetes (Barber et al. 2006). In 
female rats (Holmäng et al. 1990), testosterone administration induced insulin 
resistance, attributed to effects on glucose transport (Rincon 1996, Holmäng et al. 
1992). Another finding was reduced capillary density in the muscle, despite 
increased muscle weight (Rincon et al. 1996). Because DHT rats became insulin 
resistant, with increased body and muscle weight, they also might have had reduced 
capillary density in muscle. In line with Mannerås et al. (2007) findings in DHT-
exposed rats, elevated androgen levels are partly responsible for insulin resistance 
in muscle in PCOS women (Holte 1996). 
 
As LPva has shown promising results on body weight development, adipokine 
concentrations, and uterine weight in OVX rats (Paper I), the effects of LPva on 
metabolic features and body composition were studied in the DHT-induced rat 
model of PCOS (Paper III). 
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1.7 11beta-hydroxysteroid dehydrogenase type 1 (Paper II) 
Our focus on the enzyme 11beta-hydroxysteroid dehydrogenase type-1 (11β-
HSD1) and Hsd11b1 gene was based on results of microarray gene expression 
analysis of liver where the expression was 10-fold increased in OVX as compared 
to SHAM (Paper II). We have chosen liver for microarray analysis because it is 
one of the most important organs in the body and serves a variety of important 
functions including metabolic, vascular, immunological, secretory and excretory 
functions. It plays a key role in the carbohydrate, protein and fat metabolism in the 
human body (Mitra and Metcalf 2009). Meanwhile, for further real-time RT-PCR 
confirmation, we also used adipose tissue because it is now recognized not only as 
a storage depot for lipid but also as a regulator of metabolism, through hormones 
known as adipokines (Santos and Fonseca 2009). 11β-HSD1 enzyme is an 
NADPH-dependent enzyme mainly expressed in key metabolic tissues including 
liver and adipose tissue (Lakshmi and Monder 1988, Bujalska et al. 1997).  
 
In man, 11β-HSD1 reduces inactive cortisone to cortisol that binds to 
glucocorticoid receptors (Staab and Maser 2010) (Figure 2). In rats, 
dehydrocorticosterone is reduced to the active corticosterone (CORT) (Jamieson et 
al. 1995). Activation of 11β-HSD1 results in the production of excess tissue 
glucocorticoids. This in turn may affect glucose homeostasis, insulin action and 
adiposity, all of which are associated with visceral obesity and development of type 
2 diabetes (Masuzaki et al. 2001, Whorwood et al. 2002, Johansson et al. 2001). In 
rodents, the role of Hsd11b1 in the development of obesity and features of the 
metabolic syndrome is well established (Masuzaki et al. 2001, Masuzaki and Flier 
2003, Kotelevtsev et al. 1997, Morton et al. 2001, Morton and Seckl 2008). In 
humans, glucocorticoid excess leads to the development of visceral obesity and 
other features of the metabolic syndrome  (Friedman et al. 1996, Arnaldi et al. 
2003).  In contrast, reduction of Hsd11b1 expression, by either pharmacological 
inhibition or targeted gene disruption, prevents regeneration of active 
glucocorticoids from the inactive 11-keto forms, attenuates intrahepatic 
glucocorticoid action and increases insulin sensitivity (Walker and Best 1995, 
Alberts et al. 2002, Kotelevtsev et al. 1997, Morton 2010). In Paper II, we 
analyzed the plasma CORT levels and Hsd11b1 expressions in liver and adipose 
tissues.  
 
   9 
 
 
 
Figure 2.  Interconversion of cortisone and cortisol by the 11β-HSD system and 
glucocorticoid responses.  
From: Staab CA, Maser E. 11beta-Hydroxysteroid dehydrogenase type 1 is an 
important regulator at the interface of obesity and inflammation. J Steroid Biochem 
Mol Biol. 2010;119(1-2):56-72. Review. 
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1.8 Urinary tract infection and LPva 
Urinary tract infection (UTI) is a highly prevalent bacterial infection in women 
(Foxman 2003). Up to 50% of women will suffer at least one episode of UTI in 
their lifetime (Hooton et al 1996) with 25% likelihood to suffer recurrence (Brown 
1999, Kunin 1994, Stamm and Hooton 1993, Stapleton 1999).  
 
Under healthy conditions the urinary tract, except for the external part of urethra, is 
maintained free from microbial colonization. Yet, the perineum is a region heavily 
colonized by bacteria originating from the gastrointestinal tract. These bacteria can 
invade the urinary tract but are mostly cleared from the bladder, mainly by the 
urine flow, antimicrobial peptides and other factors effective against uropathogenic 
bacteria (Chromek et al. 2006). When bacteria colonize the bladder epithelial cells 
without strong immunological response, it is described as asymptomatic bacteriuria 
(Hooton et al. 2000). When, on the other hand, bacteria acquire different virulence 
properties which increase their ability to adapt to new niches they may also cause 
infections. Although some properties are in common, uropathogenic bacteria 
causing UTI do not have a single profile (Snyder et al. 2004, Tullus et al. 1991). 
 
Uropathogenic Escherichia coli (UPEC) is the most common cause of 
uncomplicated UTI (Gupta et al. 1999). To cause UTI, the bacteria use several 
steps; adhesion and colonization, invasion and survival and host damage. The 
virulence properties of relevance for the current study are properties enabling 
adhesion. E. coli have several distinct adhesive properties, so called fimbriae or pili 
(Mulvey  et al. 2002), which are expressed one at a time, when needed (Snyder et 
al. 2005). In the early stage of UTI, type 1 fimbriae are of importance. 
 
With increasing age, UTI becomes more common. Among postmenopausal 
women, high frequency of UTI (Hu et al. 2004) has been associated with reduced 
estrogen levels (Raz & Stamm 1993). The high incidence of UTI has led to 
investigation of plant products, such as cranberry, which may help to prevent 
infection (Guay 2009). In light of our previous findings on the phytoestrogenic 
activity of LPva (Fazliana et al. 2009), in Paper IV we investigated effects of 
LPva on the uroepithelium and its interaction with UPEC infection.  
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Figure 3: Multi-step pathogenic cascade of uropathogenic Escherichia coli (UPEC) 
UPEC coordinate highly organized temporal and spatial events to colonize the urinary 
tract. UPEC bind to and invade the superficial facet cells that line the bladder lumen, where 
they rapidly replicate to form a biofilm-like intracellular bacterial community (IBC). In the 
IBC, bacteria find safe haven, are resistant to antibiotics and subvert clearance by host 
innate immune responses. UPEC can persist for months in a quiescent bladder reservoir 
following acute infection and challenge current antimicrobial therapies. Quiescent bacteria 
can re-emerge from their protected intracellular niche and be a source of recurrent urinary-
tract infections. Insight into the processes that accompany IBC formation and biofilm 
dispersal, as well as the factors that drive bacteria into the reservoir, may aid the design of 
preventive or therapeutic strategies for recurrent infections.  
From: Cegelski et al. The biology and future prospects of antivirulence therapies. Nat Rev 
Microbiol. 2008;6(1):17-27. Review.  
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2. AIMS OF THE THESIS 
The general aim of the work in this thesis was to identify 
phytoestrogenic/biological activities by Labisia pumila var alata (LPva). The 
specific aims in the individual papers were: 
 
1. To investigate the effects of LPva extracts in relation to estrogen 
replacement (ERT) on body weight gain, uterine weight, plasma and 
mRNA expression adipokines such as leptin, adiponectin and resistin, using 
ovariectomized (OVX) rats as a model. 
 
2. To elucidate the mechanism of action of LPva by evaluating its effects on 
11beta-hydroxysteroid dehydrogenase type 1 (Hsd11b1) expression with 
the possible regulatory effects on body weight in the OVX rats. 
 
3. To investigate the effect of LPva on metabolic features and body 
composition in the dehydrotestosterone (DHT)-induced rat model of 
polycystic ovary syndrome (PCOS). 
 
4. To determine if LPva mediates protective functions against urinary tract 
infection (UTI), and investigate the mechanisms of action of LPva in a 
cell culture model of E. coli UTI.  
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3. MATERIAL AND METHODS 
This chapter describes the principles of methods that are central to the work 
presented in this thesis. For more information about these and the other methods 
used, please refer to the specific paper. 
 
3.1. Plant material and extraction procedure 
Preparation of the standardized extract of LPva was carried out at a Good 
Manufacturing Practice facility in Malaysia. Briefly, extraction involved simmering 
the plant material in water at 80°C for 3 hours followed by spray-drying to obtain 
the final LPva extract. A patent has been applied for the process for preparation of 
LPva extract to obtain an optimized and reproducible chemical profile by high 
performance liquid chromatography (USPTO Patent Application - 20070082069). 
 
3.2. Animals and treatment 
 
3.2.1 Papers I and II 
We used six-weeks old female Sprague-Dawley rats in studies of Papers I and II 
(Figure 4). The rats were OVX and randomly assigned to different treatments 
(ERT- estrogen replacement and LPva10, 20 and 50-Labisia pumila 10, 20 and 
50mg/kg respectively). A control group was sham-operated (SHAM). At the time 
of surgery, all rats had similar body weight. Treatments were started 2 weeks after 
OVX. The study protocol was approved by the Animal Care and Use Committee 
(ACUC), Ministry of Health Malaysia and the Stockholm North Animal Ethics 
Committee. The ERT dose used in this study was an extrapolation of the human 
dosage of 0.625 mg/day. 
 
At the end of the experiments, all animals were anaesthesized with pentobarbital 
and blood was collected, centrifuged, and plasma was stored at -20˚C. Liver and 
adipose tissue were removed and stored in RNA later (detail information in ‘tissue 
collection’ section). 
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Figure 4. The schedule of treatment. 
 
3.2.2 Paper III 
At the age of 21 days, the female Wistar rats were implanted subcutaneously in the 
neck with a 90-d continuous-release pellet (Innovative Research of America, 
Sarasota, FL) containing 7.5 mg of DHT (daily dose, 83 µg) (Figure 5). A 
microchip (AVID, Norco, CA) with an identification number was inserted along 
with the pellets. After 7 wk of DHT exposure, rats were randomized into two 
groups, PCOS LPva and PCOS control. The PCOS LPva group received extracted 
LPva orally (50 mg/kg of body weight dissolved in 1 ml of distilled water) daily 
during 4-5 weeks; the PCOS control group received 1 ml of distilled water. The rats 
were weighed weekly from the day of pellet implantation to the end of the study. 
The study was concluded when the rats were 14–15 wk of age (i.e., after 10–11 wk 
of DHT administration). Animals were cared for in accordance with the principles 
of the Guide to the Care and Use of Experimental Animals and the study was 
approved by the Animal Ethics Committee of the University of Gothenburg. 
 
 
 
Figure 5. Schematic diagram of LPva treatment on DHT-induced PCOS rats. 
Treatment start (62d)DHT pellet (21d)
Blood sampling (88d)
DEXA (89d) Euglycemic hyperinsulinemic clamp (92-99d)
0 7 14 21 28 35 42 49 56 7063 918477 98
PCOS Control (n=11)
PCOS Labisia Pumila (n=11)
Days of age
PCOS (n=22)
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3.3 Blood sampling, tissues collection and endocrine analysis (Papers I-III) 
For Papers I and II, at the end of animal experiments, the rats were killed and liver 
and adipose tissues were put into 5 volumes of RNAlater stabilization solution 
(Ambion, Austin, TX) for 24 h at 4°C and then stored at –80° C for mRNA 
analyses. Uterus were dissected and weighed.  Blood was collected for plasma 
analysis of leptin (RIA kit, LINCO Research, Inc., St. Charles, MO, USA), resistin 
(ELISA kit, Diagnostic Systems Laboratories, Webster, TX), adiponectin (ELISA, 
GenWay Biotech Inc., San Diego, USA) and corticosterone (ELISA kit, Diagnostic 
Systems Laboratories, Webster, TX). 
 
For Paper III, tail blood was taken after an overnight fast for analyses of lipid 
profile (total cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], high-
density lipoprotein cholesterol [HDL-C], and triglycerides [TG]), leptin, 
adiponectin and resistin. Plasma concentrations of TC, LDL-C, HDL-C, and TG 
were determined enzymatically with a Konelab autoanalyzer 2.0 (Thermo Clinical 
Labsystems, Espoo, Finland). Enzyme immunoassays were used to determine the 
levels of leptin (rat leptin ELISA kit, EZRL-83K; Lincon Research, St. Charles, 
MO), adiponectin (rat adiponectin ELISA kit, CYT288; Chemicon International, 
Billerica, MA, and resistin (rat resistin ELISA, RD391016200R; BioVendor, 
Heidelberg, Germany). Human insulin, given during the clamp, was measured with 
an enzyme immunoassay (insulin ELISA, 10-1113-01; Mercodia, Uppsala, 
Sweden). 
 
3.4 Body composition (Paper III) 
Body composition was analyzed at 14 wk of age by whole-body dual-emission X-
ray absorptiometry (DEXA) with a whole-body densitometer (QDR-100/W, 
Hologic, Waltham, MA). DEXA was originally intended for bone density 
analysis. However, it has become a widely used non-invasive technique for the 
investigation of body composition in humans and animals. The technique is based 
on the physics principle that X-rays of different energies are attenuated 
differently when passing through the body. The differential attenuation of the two 
energies is used to estimate the bone mineral content and the soft tissue 
composition. 
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3.5 Euglycemic hyperinsulinemic clamp (Paper III) 
At 14–15 wk of age (i.e., after 4–5 wk of treatment, 10–11 wk after pellet 
implantation), rats were subjected to an euglycemic-hyperinsulinemic clamp. It is 
regarded as a gold standard to quantify insulin sensitivity in vivo. This technique 
measures the steady state amount of glucose metabolized per unit body weight 
during a whole-body exposure to a pre-determined amount of insulin, while 
maintaining the amount of plasma glucose within the euglycemic range (DeFronzo 
et al. 1979). The clamp technique is the most widely used method in the research 
setting and is highly reproducible (Soop et al 2000). Plasma insulin concentration 
is acutely increased and maintained by a continuous infusion of insulin. Blood 
glucose levels are “clamped” at basal levels (euglycemic levels) by a 
simultaneous variable glucose infusion. Because endogenous hepatic glucose 
production is inhibited at high insulin concentrations, the amount of glucose 
infused per unit of time to maintain euglycemia reflects the amount of glucose 
metabolized in the peripheral tissues and is therefore an indirect index of the 
sensitivity of tissue to exogenous insulin. The insulin sensitivity index obtained 
by the clamp technique is basically the mean glucose infusion rate at steady state 
and termed glucose infusion rate (GIR) or glucose disposal rate (GDR or M), 
which is normalized to body weight (mg/kg x min). The degree of insulin 
resistance is inversely proportional to the glucose uptake by tissues during the 
procedure. Accordingly, an insulin-resistant subject requires less glucose to 
maintain euglycemia and has therefore a low GIR/GDR value. 
 
The rats were anesthetized with thiobutabarbital sodium (130 mg/kg i.p.; Inactin, 
Sigma, St. Louis, MO). Catheters were inserted into the left carotid artery and the 
right jugular vein. A tracheotomy was performed to facilitate respiration. Body 
temperature was maintained at 37°C with a heating pad. Insulin (100 IU/ml; 
Actrapid, Novo Nordisk, Bagsvaerd, Denmark) together with 0.2 ml of albumin 
and 10 ml of physiological saline was infused at 24, 16, and 12 mU/min/kg for 1, 2, 
and 3 min respectively, followed by 8 mU/min/kg for the rest of the clamp. 
Simultaneously, a 20% glucose solution in physiological saline was administered to 
maintain blood glucose levels at a euglycemic level (6.0 mM). The glucose 
infusion rate was guided by measuring glucose concentration every 5 min with a B-
glucose analyser (Hemocue, Dronfield, Derbyshire, UK). The mean glucose 
infusion rate, normalized to body weight, was calculated at steady state (after 
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approximately 50–70 min) as an index of insulin sensitivity. Blood samples were 
taken at the end of the clamp to determine insulin concentrations. 
 
3.6 RNA extraction and Taqman real-time RT-PCR (Papers I-IV) 
One way of analyzing the expression of peptides or proteins is to study the levels of 
their messenger RNAs (mRNA). Real-time reverse transcriptase (RT)-PCR is 
thought to be the most sensitive method for the detection and quantification of 
specific mRNA. 
 
This method is based on the general principle of PCR, by which the target is 
amplified during the process. However, real-time RT-PCR is a “two-step” method 
for quantifying mRNA. Firstly, total RNA which is unstable is isolated and 
reversely transcribed into complementary DNA (cDNA), which is very stable and 
may be stored for years in the freezer. In the second step, PCR amplifies the 
cDNA using primers and a probe complementary to the target sequence.  
 
The Taqman probes have a reporter fluorophore in its 5’ end and quencher in its 3’ 
end. This assay is based on the fluorescence resonance energy transfer (FRET) 
which means that when the probe is intact the fluorescence emission of the reporter 
absorbed by the quencher. As soon as the probe has annealed to a target sequence 
and Taq DNA polymerase cleaves the probe, in the extension phase of the PCR 
reaction, the reporter and quencher will be separated from each other and 
fluorescence can be detected and measured (Arya et al 2005). This technique 
continuously monitors the cycle-by cycle accumulation of the fluorescently labeled 
PCR produced (Walker 2002).  
 
Quantification can either be relative to an external standard curve or to one or more 
co-amplified internal mRNAs. Quantification relative to internal control mRNAs 
compares the Ct (threshold cycle) values from target RNAs to those of one or more 
internal reference genes (housekeeping genes) and results are expressed as ratios of 
the target-specific signal to the internal reference (Papers I-III).  In Paper IV, 
relative quantification was done according to the comparative Ct (2-Ct) method. 
18S ribosomal RNA (18S rRNA) was used as endogenous control. 
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Total RNA isolations were performed using TRI reagent (Paper I), RNeasy Lipid 
Tissue Mini Kit (Qiagen) (Paper II) and RNeasy Mini Kit (Qiagen) (Papers II 
and IV) and RiboPure Kit (Ambion) (Paper III). The tissues were disrupted using 
mini beadbeater (BiospecProducts, Bartlesville, OK, USA) with 0.5 ml of 2-mm 
diameter Zirconia beads or (1-mm  glass beads) and further processed with the 
manufacturers’ protocol. Total RNA was transcribed into cDNA using Omniscript 
Reverse Transcriptase (Qiagen) in Paper I, Reverse Transcription Reagents 
(Applied Biosystem, Foster City, CA, USA) in Papers II and III, and DyNAmo 
cDNA Synthesis Kit (Finnzymes, Espoo, Finland) in Paper IV with random 
hexamer primers. Reaction volume was 20µl in all studies. Pre-developed Taqman 
Gene Expression Assay (Applied Biosystems) containing probe and primers for 
genes were evaluated in all papers. 
 
3.7 Western blotting (Papers II and IV) 
Western blot is a technique to identify and locate proteins with help of specific 
antibodies. The proteins are analyzed from liver and adipose tissues (Paper II) and 
T24 cells (Paper IV) that have been lysed in lysis buffers with protease inhibitors. 
The proteins in the lysates are separated by molecular mass, on 10 % and 12% Tris-
HCl gels using electrophoresis. After that the proteins are blotted on to 0.45 µm 
PVDF membrane (Invitrolon, PVDF⁄Filter Paper Sandwich, LC2007, Invitrogen) 
using an electrical field. The transferred proteins are bound to the surface of the 
membrane providing access for the reaction with antibodies. The membrane is first 
blocked with 5% non-fat milk to prevent unspecific antigen interactions. Then the 
antibody-antigen complexes are identified with horseradish peroxidase (HRP) 
enzyme conjugated to the secondary anti-IgG antibody (species specific). The 
HRP-conjugated antibody can easily be detected by a phosphor imager instrument.  
 
Antibodies used were rabbit anti-11β-HSD1 (1:300; Abcam, Cambridge, MA, 
USA) and HRP-conjugated anti-rabbit antibody (1:50,000; Abcam) for Paper II. 
For Paper IV, antibodies used were goat anti-caveolin-1 (1:500; Abd Serotec, 
Oxford, UK) and HRP-conjugated anti-goat antibody (1:1000, Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). 
 
For a loading control, we used rabbit anti-β-tubulin conjugated with HRP at a 1:200 
dilution of 200 mg/ml (Abcam) and rabbit anti-GAPDH antibodies (1:1000; Cell 
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Signaling Technology, Danvers, MA, USA) for Papers II and IV respectively. 
Proteins were visualized using a chemiluminescence detection kit, Super Signal 
West Pico kit (Pierce, Thermo Scientific, Waltham, MA, USA) and imaged using a 
FujiLas CCD camera. Band intensity was quantified with ImageJ (NIH) and 
normalized to β-tubulin (Paper II) and GAPDH (Paper IV) in the same sample.  
 
3.8 Microarray (Paper II) 
The target preparation starts with isolating total RNA. Total RNA was prepared 
from frozen tissue using TRIZOL Reagent (Invitrogen, Carlsbad, CA, USA) and 
purified using RNeasy Mini Kits (Qiagen, Valencia, CA, USA). The RNA was 
reversed transcribed into cDNA by the use of primer that includes a poly(T) tail 
and a T7 polymerase binding site. Both first strand and second strand cDNA 
synthesis were performed. The double stranded cDNA was used in in vitro 
transcription (IVT) where biotinylated nucleotides were incorporated into the 
target, resulting in a biotin-labeld complementary RNA (cRNA) sample. The 
synthesized labeled cRNA was then hybridized onto Affymetrix Rat genome 230 
2.0 array, which were washed and scanned. Output files from microarray analyses 
were analyzed using Affymetrix GeneChip Operating Software. Scanned data files 
were analyzed using Partek software (Partek Inc., St Louis, MO, USA). Probe set 
data were summarized, background adjusted, and quantile normalized using robust 
multichip average methodology. A false discovery rate correction was applied to 
post hoc pairwise group comparisons of Pearson's correlation coefficients obtained 
by ANOVA. Heat map and clustering of the gene expression data were also 
generated using Partek. P <0.05 was considered significant, with an arbitrary 
threshold of 3-fold difference between the six groups analyzed simultaneously. 
After retrieving a list of statistically significant genes, one has to verify the findings 
with some other methods. In our studies, real-time RT-PCR and Western blotting 
were used to confirm the results. 
 
3.9 Cell culture, LPva treatment and bacteria (Paper IV) 
The T24 human bladder epithelial cell (BEC) line (ATCC HTB-4), obtained from 
the American Type Culture Collection (Rockville, MD, USA), was used to model 
the human uroepithelium. T24 cells were maintained in McCoy’s 5A medium with 
L-glutamine (Gibco, Carlsbad, CA, USA) and supplemented with 10% fetal bovine 
serum (Gibco). Cells were grown in 6- or 24-well tissue culture plates (Sarstedt Inc, 
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Newton, NC, USA and Costar, Corning, NY, USA, respectively) and maintained 
before and during infections at 37°C in a humidified incubator with 5% CO2. Cells 
were treated with 100 or 1000 µg/ml LPva, beginning on the day after cells 
seeding. The LPva concentration used was determined by extrapolation of doses 
used in previous animal experiments (Fazliana et al. 2009). Medium containing 
LPva was renewed daily and experiments were performed after 72 h of treatment. 
In all experiments, untreated (control) cells were grown and handled in parallel 
with LPva-treated cells.  
 
Viability and proliferation of cells treated with LPva was confirmed by XTT assay. 
Well characterized UPEC strain E.coli CFT073 was used. Prior to experiments, 
UPEC strain CFT073 was cultured in Luria-Bertani (LB) broth with agitation 
(37°C) to log phase. The culture was centrifuged (2500 x g, 10 min) and the pellet 
resuspended in PBS. The concentration of the suspension was determined by 
spectrophotometer (OD 600 nm). A final concentration of approximately 1.0 x 107 
CFU/ml was used for infection.  
 
3.10 Apoptosis assays (Paper IV) 
T24 cells grown on coverslips overnight in 24-well plates were treated with 100 
µg/ml or 1000 µg/ml LPva for 6, 24 or 72 h. Staining of cells was performed using 
the Annexin-V-FLUOS staining kit and the in situ cell death detection kit (TUNEL 
assay) (Roche Applied Science), according to manufacturer instructions. Annexin-
V-FLUOS labels phosphatidylserine which is produced in the early stages of 
apoptosis while the TUNEL assay labels DNA strand breaks generated during 
apoptosis. Coverslips were mounted onto glass slides using ProLong Gold Antifade 
Reagent (Invitrogen). Cells were examined with a Leica TCS SP5 confocal 
microscope at 20x objective and appropriate filter settings.  
 
3.11 Infection assays (Paper IV) 
The effect of LPva treatment on UTI was assessed by employing two assays to 
measure total number of cell-associated bacteria (attachment assay, modified from 
Kai-Larsen et al. 2009) and the number of intracellular bacteria only (invasion 
assay, modified from Guignot  et al. 2009).  Cells grown in 24-well plates were 
infected with E.coli CFT073 for 30 minutes, then washed three times with PBS to 
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remove non-adherent bacteria. To collect the total number of bacteria, cells were 
lysed with 1% Triton X-100 in PBS. The lysate was serially diluted and plated on 
blood agar plates. Bacterial counts were determined following overnight incubation 
at 37°C. 
 
To determine the number of intracellular bacteria, fresh medium was added and 
cells were incubated for a further 90 min to allow bacterial entry into BEC. Cells 
were washed once with PBS and incubated for 1 h with fresh medium containing 
100 µg/ml gentamicin (Sigma-Aldrich) to kill extracellular bacteria. Thereafter, 
cells were washed with PBS, lysed and treated as above. In treated cells, medium 
supplemented with LPva was used throughout the entire experiment. 
 
3.12 Statistical analysis 
All values reported are expressed as mean±SEM. Differences between means were 
analyzed for significance by one-way ANOVA, followed by Tukey’s post hoc test 
(Papers I and II) and Mann-Whitney U test (Paper III and IV). p < 0.05 was 
considered significant. 
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4. Results 
 
4.1 Uterotrophic effects of LPva 
Administration of LPva to ovariectomized rats dose-dependently increased 
uterus-to-body weight ratio, indicating that LPva contains estrogen-like 
compounds (Paper I) (Figure 6). In Paper III, the uterus was 27% heavier in the 
PCOS LPva group than in PCOS controls (Figure 7).  
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Figure 6. Uterus to body weight ratio. 
Data are means  SEM. *p<0.05 vs OVX control, **p<0.01 vs OVX control, # p<0.05 vs 
ERT, # # p<0.01 vs ERT, § p<0.05 vs Sham, §§ p<0.01 vs Sham and θ p<0.05 vs 
LPva10.  
 
 
 
 
PCOS Control (n=8) PCOS LP (n=10)
0.0
0.1
0.2
0.3
0.4
0.5
*
U
te
ru
s 
w
ei
gh
t (
g)
 
Figure 7.  Uterus weight in PCOS control rats and PCOS-LPva rats. 
Values are mean ± SEM. * P < 0.05 
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4.2 Body weight gain. 
OVX rat model (Paper I) showed a dose-dependent trend with increasing 
concentrations of LPva towards a decrease in body weight gain that was 
significant (P < 0.05) at a dose of 50 mg/kg/day (Figure 8). However, LPva had 
no effect on body weight in the PCOS model (Paper III).  
 
Figure 8.  Body weight gain. *p<0.05 vs OVX control.  
 
4.3 Food intake 
Compared to the SHAM group, OVX rats showed highest daily food consumption 
at the end of the study (Figure 9).  At week-6, mean food intake was lowest 
amongst the ERT rats (p<0.05).  Although LPva50 showed significant difference 
compared to OVX, there was no significant difference in food intake amongst the 
LPva-treated groups. 
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Figure 9. Daily food intake. *p<0.05 vs OVX control 
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4.4 Glucose and insulin in plasma and insulin sensitivity 
 
In Paper I, fasting plasma insulin levels were significantly higher in the ERT-
treated and LPva50 rats compared to the OVX control group. However, there was 
no significant change in the levels of plasma glucose. Interestingly, in the PCOS 
model (Paper III), the glucose infusion rate, determined by a euglycemic-
hyperinsulinemic clamp, was 35% higher in LPva-treated rats than in controls, 
indicating improved insulin sensitivity (Figure 10).   
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Figure 10. Glucose infusion rate, at steady state, required to maintain euglycemia during 
euglycemic-hyperinsulinemic clamp in PCOS control rats and PCOS LPva  rats. Values are 
mean ± SEM. * P < 0.05 
 
 
4.5 Adipokines expressions 
Ovariectomy decreased leptin mRNA levels, and LPva treatment but not ERT 
significantly increased the levels, the highest being in the LPva10 group (p < 0.01 
vs OVX, SHAM, ERT). Similar trend was also observed for plasma leptin. The low 
leptin levels in OVX control were restored when OVX rats received ERT or LPva 
extracts (p < 0.05) (Figure 11). 
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Figure 11. Expressions of leptin, resistin and adiponectin at mRNA (left column)  and 
protein levels (right column). * p<0.05 vs OVX control, ** p<0.01 vs OVX control,   # p<0.05 
vs ERT, ## p<0.01 vs ERT,   § p<0.05 vs Sham, §§ p<0.01 vs Sham and θ p<0.05 vs LP10. 
 
 
The plasma and mRNA levels of resistin were increased after ovariectomy and 
decreased remarkably when rats were treated with ERT (p < 0.01). Although not 
significant, reduction of mRNA levels in the adipose tissue was also observed in 
the OVX rats treated with LPva. Compared to the SHAM group, plasma resistin 
levels were significantly lower in LPva20, LPva50-treated and ERT-treated rats (p 
< 0.05 for all).  
 
Ovariectomy had no significant effect on the protein and mRNA expression 
levels of adiponectin. Plasma adiponectin levels in SHAM, OVX control, ERT 
and LPva groups remained comparable. However, compared to the SHAM, OVX 
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control and ERT, mRNA expression levels of adiponectin were elevated in 
LPva10 group (p < 0.05). 
 
In Paper III, resistin levels were higher in the LPva group than in PCOS-
controls (Table 1). Circulating adiponectin levels trended higher after treatment 
with LPva, but the difference was not statistically significant. Circulating leptin 
levels were unaffected by treatment, despite decreased the expression of leptin 
mRNA in mesenteric adipose tissue (Figure 12). 
 
Adipokine 
 
PCOS control  
(n = 10–11) 
PCOS LPva 
 (n = 11) 
Mann–Whitney 
P value 
Resistin (ng/ml) 20.72 ± 1.54 25.32 ± 0.92 *0.023 
Adiponectin 
(µg/ml) 
18.26 ± 2.02 24.02 ± 2.00   0.071 
Leptin (ng/ml) 6.05 ± 1.14 4.52 ± 0.75   0.360 
Table 1: Circulating levels of adipokines. Values are mean ± SEM. 
 
Resistin Leptin Adiponectin
0.0
2.5
5.0
7.5
10.0
PCOS Control (n=8)
PCOS LPva (n=10)
**
R
es
is
tin
/L
ep
tin
/A
di
po
ne
ct
in
 m
R
N
A
(A
rb
itr
ar
y 
U
ni
t)
 
Figure 12. Relative mRNA expression levels of resistin, adiponectin and 
leptin in adipose tissue of PCOS control rats and PCOS LPva rats. Values are 
mean ± SEM. ** P < 0.01  
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4.6 Lipid profiles 
After treatment with LPva, PCOS rats displayed an improved lipid profile, 
illustrated by decreased levels of TC and TG. HDL-C and LDL-C levels were 
similar in PCOS LPva rats and PCOS controls (Figure 13). 
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Figure 13. Lipid profile in PCOS LPva rats and PCOS controls. 
Values are mean±SEM. *P < 0.05 vs. control (Mann–Whitney U test). 
 
 
 
4.7 Hsd11b1 
4.7.1  Real-time RT-PCR analysis 
The microarray analysis of liver tissues revealed that Hsd11b1 expression was 10-
fold increased in OVX compared to SHAM. All three treatment doses of LPva 
reduced the Hsd11b1 expression more than three times as compared to OVX, the 
expressions however being 2 to 3 fold increased as compared to SHAM (Table 2). 
These reductions were not as big as noted after treatment by ERT. To confirm the 
microarray data, we carried out real-time RT-PCR on mRNA from liver and 
adipose tissue. Even though the trends seemed similar in both tissues, the Hsd11b1 
mRNA expression in OVX increased more in the liver than in adipose tissue 
(Figure 14A and 14B). This increase was normalized in both liver and adipose 
tissue by treatment with all doses of LPva (LPva10, LPva20, LPva50), while ERT 
normalized the expression only in liver.  
 
Groups Fold-change vs SHAM 
OVX 10.42 
ERT 1.43 
LPva10 2.98 
LPva20 2.62 
LPva50 2.39 
Table 2. Microarray results of Hsd11b1 gene 
 28 
4.7.2 Protein levels by Western blot and corticosterone 
In parallel, the 11β-HSD1 protein levels, as observed in Western blotting analysis, 
increased in both tissues in OVX rats, and were normalized after treatment with 
LPva or ERT (Figure 14C and 14D).  OVX significantly increased plasma CORT 
levels compared to SHAM group. All doses of LPva and ERT reduced the plasma 
CORT levels (Table 3).  
 
Groups Corticosterone ng/ml 
SHAM 53 ± 18 
OVX 135 ± 11* # § 
ERT 88 ± 22 
LPva 10 85 ± 27 
LPva 20 95 ± 23 
LPva 50 92 ± 16 
Table 3. Plasma corticosterone levels were measured by ELISA. 
*p < 0.05 vs SHAM, #p<0.05 vs ERT, § p < 0.05 vs. all LPva10, 
LPva20 and LPva50. 
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Figure 14. Hsd11b1 mRNA expression levels in liver (A) and adipose tissue (B).  
11ß-HSD1 protein levels in liver (C) and adipose tissues (D). E and F, representative 
Western blots for the 11ß-HSD1 proteins for liver and adipose tissues, respectively. 
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4.8 UPEC and LPva     
4.8.1 LPva induces apoptosis in bladder epithelial cells. 
We investigated the effect of LPva on epithelial cells and demonstrate that LPva 
treatment induces programmed cell death of BEC. Apoptosis was seen at both 6 
and 24 h using the Annexin-V-FLUOS assay, suggesting that LPva had the 
potential to induce cell death (Figure 15). 
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Figure 15. Apoptosis induced by LPva treatment in T24 bladder epithelial cells. 
The Annexin assay revealed apoptosis in 100 µg/ml and 1000 µg/ml LPva-treated 
cells. (A) Apoptosis (stained green with Annexin-V) was seen among non-infected 
24 h 100 µg/ml LPva-treated cells and (B) following UPEC CFT073 infection. (C) 
No apoptosis was seen in untreated control cells however, (D) necrotic cells 
(stained red with propidium iodide) were detected following UPEC infection. All 
cells were stained with DAPI (blue) to detect the cell nucleus. Images shown are 
those following 24 h of treatment. Similar results were seen after 6 h. In the 
TUNEL assay, apoptosis (stained green with TUNEL reaction) was observed in all 
6 h (E) and 24 h (F) 1000 µg/ml LPva-treated cells. 
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4.8.2 LPva treatment increases expression of caveolin-1. 
Due to our finding that LPva treatment induces apoptosis in T24 cells, we next 
explored the expression of caveolin-1 which has been associated with this process 
(Liu et al 2001, Gargalovic and Dory 2003).  A significant upregulation of 
caveolin-1 was found in LPva-treated cells compared to untreated cells, on both the 
mRNA and protein levels (Figure 16).  
 
 
 
Figure 16. The mRNA and protein levels of caveolin-1 in LPva-treated T24 bladder 
epithelial cells with and without E. coli CFT073 infection. (A) Expression of caveolin-
1 mRNA was significantly up-regulated in 6 h 100 µg/ml LPva-treated non-infected cells 
compared to untreated controls (**P = 0.01). An upregulation was also observed among 
treated cells following E. coli CFT073 infection compared to untreated cells (4 
independent assays with 3 replicates) (***P = 0.001). (B) In uninfected 72 h LPva-
treated cells, caveolin-1 protein was expressed significantly compared to untreated cells 
(3 independent experiments) (*P < 0.05). Blots were stripped and reprobed with 
antibodies against GAPDH to correct for differences in protein loading. Quantification of 
Western blot analyses was performed using ImageJ Software. All values shown are 
means ± standard error of the mean. (C) Representative Western blots for the caveolin-1 
protein expressed in untreated or LPva-treated cells with and without UPEC infection.  
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4.8.3 LPva does not exhibit antimicrobial activity.                                                                
To elucidate the possible antimicrobial effect of LPva, sensitivity assays were 
performed. No detectable zone of inhibition was induced by LPva, indicating no 
direct inhibitory activity. Furthermore, mRNA expressions of the antimicrobial 
peptides LL-37 and HBD-2 were not upregulated compared to untreated cells 
suggesting that LPva did not influence BEC antimicrobial responses.  
 
4.8.4 LPva reduces the amount of intracellular UPEC. 
The number of intracellular bacteria was significantly reduced in LPva-treated cells 
(P = 0.01) (Figure 17A). However, this was not due to interference of FimH on 
type 1 fimbriae nor to an overall decreased bacterial attachment (Figure 17B). 
Instead, we demonstrate that the expression of the invasion mediating protein, -1 
integrin decreased significantly.  
 
 
Figure 17. Level of attachment and invasion by UPEC CFT073 in LPva-treated 
BECs.  
(A) Treatment was associated with a significant decrease in the level of intracellular 
bacteria (3 independent assays with 6 replicates) (**P = 0.01) (B) However, LPva 
treatment did not affect attachment. Values shown are means ± standard error of the mean. 
(C) β1 integrin mRNA expression was significantly down-regulated in LPva-treated cells 
compared to controls (4 independent assays with 3 replicates) (**P = 0.01). Values 
shown are means ± standard error.  
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5. Discussion 
In our studies, we have found various effects by LPva in different animal models 
and cell lines. Even though LPva extract did not bind to estrogen receptor-alpha 
and -beta in the receptor binding assays (data not shown), it has been shown to 
mimic estrogenic effects to certain extent. These findings indicated that the 
components of LPva induced estrogenic effects through targets and signaling 
pathways other than those of estrogen; for example, by promoting adrenal gland 
secretion or local biosynthesis at peripheral tissues (Ma et al. 2010). 
 
5.1 Uterotrophic effects and body weight changes by LPva 
In OVX rats, the lack of estrogen causes atrophy of the uterus. Therefore, as found 
in our study, OVX resulted in a dramatic decrease in the uterine weight (Rachon´ et 
al. 2007, García-Pérez et al. 2006). LPva significantly recovered the weight of the 
uterus atrophied by OVX (Figure 6), indicating that LPva exerts estrogen-like 
effects.  
 
As expected and as have been reported by others, ERT administration decreased 
body weight gain in the OVX rats (Shinoda et al. 2002, Tanaka et al. 2001, Sivan 
et al. 1998, Alonso et al. 2007, Gorzek et al. 2007).  Interestingly, LPva exerted 
similar effect and at doses ranging between 10 to 50 mg/kg/day prevented further 
increase in body weight gain in the control OVX rats. However, no change in body 
weight by LPva treatment was observed in the PCOS rats model. Effects of LPva 
differ in some parts from findings in the Papers I and III. The main reason for this 
is most likely the use of two animal models displaying different endocrine and 
metabolic characteristics. Despite these differences regarding effects on body 
weight, LPva exerted an uterotrophic effect in both models. 
 
5.2 Insulin sensitivity and adipokines 
In the OVX study (Paper I), plasma glucose levels did not differ between the 
groups, but plasma insulin concentrations were elevated in the ERT and LPva50 
groups, indicating decreased insulin sensitivity. Treatment of OVX rats with 17-β 
estradiol has been shown to decrease the amount of peripheral insulin receptors and 
lead to reduce insulin sensitivity (Gonzales et al. 2002). These effects were dose-
dependent and a high dose of 17-β estradiol was related to the down-regulation of 
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insulin receptor substrate-1 (IRS-1) expression (Gonzales et al. 2003). These 
effects indicate the presence of phytoestrogen in the extract. 
 
In concert with a previous study (Yoneda et al 1998), we found inverse correlation 
between adipose tissues leptin mRNA expression and body weight gain in the 
OVX rat model.  In fact, as body weight increased following ovariectomy, leptin 
declined significantly to levels less than 50% of those seen in the SHAM rats. Our 
results are thus in agreement with several other studies where ovariectomy was 
shown to result in decreased plasma leptin levels in the experimental rats studies 
(Chu et al. 1999, Yoneda et al. 1998,  Brann et al. 1999). Decrease in leptin has 
been suggested to result in reduced control of appetite and the lower amount of 
energy spent, and hence, increase in body weight in the OVX rats (Kimura et al. 
2002).  The upregulation of leptin mRNA expression in the adipocyte tissues and 
the higher plasma leptin levels seen in OVX rats treated with LPva is at least in 
part, due to the presence of phytoestrogens in the extract. 
 
Leptin mRNA levels were restored in the estradiol-treated rats, comparable to that 
observed in the SHAM rats, suggesting the involvement of ovarian steroids in the 
regulation of leptin gene (Brann et al. 1999). Estrogen also caused increased leptin 
mRNA levels in cultured adipocytes in vitro (Kristensen et al. 1999) while in 
another study, OVX induced a 25% decrease in leptin gene mRNA expression in 
fat cells (Machinal et al. 1999). Compared to ERT, LPva induced significantly 
higher leptin mRNA levels in the adipose tissue of the treated rats.  
 
Resistin is a signaling molecule that is induced during adipogenesis and secreted by 
the adipocytes (Steppan et al. 2001). The molecule is proposed to be involved in 
insulin resistance and type 2 diabetes. Our results indicate that resistin levels of 
mRNA and in plasma  are increased in OVX rats and reduced when rats were given 
ERT and LPva. These results clearly showed that resistin protein and mRNA 
expression was suppressed by ERT and LPva.  Huang et al. (2005) showed that 
mRNA levels were down-regulated by estrogen both in vivo and in vitro.  
 
In Paper III, the plasma resistin levels were increased in the PCOS LPva group. 
Since LPva improved insulin sensitivity without influencing body weight or 
adipocity, the increase in plasma resistin levels appeared to lack clinical effect in 
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this context, or was  counter-acted by other factors regulating insulin sensitivity. 
Furthermore, insulin resistance in PCOS  appears independent of obesity, since 
even lean women with PCOS are more insulin resistant than weight-matched 
controls (Dunaif et al. 1989).  
 
 If LPva works through estrogenic pathways, this is consistent with in vitro studies 
of adipocytes showing that 17β-estradiol stimulates resistin gene expression (Chen 
et al. 2006, Lee et al. 2008). Despite increased plasma levels of resistin in LPva-
treated rats in the present study, mRNA expression was not significantly different 
between the two groups. A possible explanation is that resistin expression is 
affected by LPva differentially in different adipose depots or other cell types 
(Steppan and Lazar 2004).  
 
Adiponectin is an adipocyte-derived plasma protein with important insulin-
sensitizing properties. In contrast to other adipokines e.g. leptin, reduced levels of 
adiponectin are associated with metabolic abnormalities such as insulin resistance 
and obesity (Weyer et al. 2001). In Paper III, there was a tendency toward higher 
circulating levels of adiponectin after treatment in LPva-treated rats than in 
controls, despite similar body weight and body composition. This finding supports 
the theory that LPva has positive metabolic effects in our PCOS rat model. 
However, adiponectin mRNA expression levels were similar in the two groups. In 
Paper I, ovariectomy has no effect on the plasma adiponectin levels and there 
was no signiﬁcant difference between OVX control and other treated-groups 
(Nishizawa et al. 2002). 
 
No difference was found in circulating leptin levels between PCOS LPva and 
PCOS control rats, probably because of the lack of change in body fat after LPva 
exposure. In contrast, leptin expression in mesenteric adipose tissue of LPva-
treated group was decreased. One possible explanation for this discrepancy is that 
LPva directly affects leptin mRNA expression in mesenteric adipose tissue but not 
in other adipose depots.  
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5.3 Hsd11b1 and corticosterone  
Our focus on Hsd11b1 is based upon microarray analysis of liver tissues where the 
expression of this gene was 10-fold augmented in OVX compared to SHAM. Up-
regulation of Hsd11b1 expression in OVX rats has been suggested to be related to 
overweight rather than lack of estrogen (Paulsen et al. 2008). However, we have 
demonstrated in Paper I that LPva and ERT exerted similar effects in reducing the 
body weight gain as seen in OVX rats (Fazliana et al. 2009). This may, at least in 
part, explain the effect of LPva and ERT on regulation of Hsd11b1. 
 
In rats, 11β-HSD1 converts 11-dehydrocorticosterone to active CORT. Our finding 
that OVX induces a rise in CORT production is in agreement with other studies 
showing that ovariectomy induced rise in serum CORT production in rats 
(Petersson et al. 2005, Cao et al. 2008, Kour et al. 2010, Pelleymounter et al. 
1999).  The CORT levels were normalized when the OVX rats were treated with 
LPva and ERT, suggesting a  reduction of  11β-HSD1 protein and Hsd11b1 mRNA 
expression levels by a direct effect. We also observed positive relations between 
mRNA expression of Hsd11b1 in liver and adipose tissues and circulating levels of 
CORT. Increased 11β-HSD1 activity in adipose tissues and liver might contribute 
to the several features of metabolic syndrome (Anagnostis et al. 2009). The mRNA 
expressions in both liver and adipose were increased in the OVX group but 
significantly reduced by LPva treatment. It is proven that 17-beta estradiol inhibits 
11β-HSD1 activity in rodent adipocytes. (Tagawa et al. 2009). Our result is 
concordant with Jamieson et al (1999) which showed that estrogen suppresses 
hepatic Hsd11b1 expression. In another study, Blum et al. (2009) explained that the 
inhibition of Hsd11b1 counter-acted  fat accumulation and related metabolic 
abnormalities in type 2 diabetes. The finding that ERT and LPva normalized the 
increased expressions of Hsd11b1 in the liver and adipose of OVX rats might 
explain this phenomenon. 
 
In this context, it is of interest that a study had demonstrated that insulin decreased 
Hsd11b1 mRNA in cultured hepatocytes (Jamieson et al. 1995).  In Paper I 
(Fazliana et al. 2009), insulin was increased in LPva treated rats, despite normal 
blood glucose levels. It is possible that increased plasma insulin levels, at least 
partly, can account for the reduced Hsd11b1 expression following LPva treatment. 
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As this is the first attempt to explore differential display of Hsd11b1 gene 
expression in OVX rat liver and adipose treated with LPva, this study partly 
explains the regulation of CORT and body weight change. Based on our results, we 
hypothesize that the anti-obesity effect of LPva is attributed, at least to some extent, 
to the inhibition of Hsd11b1 expression in adipose tissue and liver. Therefore, the 
use of LPva can be explored to reduce glucocorticoid action as the basis for novel 
therapy of type 2 diabetes and obesity. 
 
5.4 Apoptosis in uroepithelial cells  
In this paper, we show that LPva treatment induced apoptosis in BECs, 
accompanied by elevated levels of caveolin-1. The plant antioxidant component, 
anthocyanin, also present in LPva (Norhaiza et al. 2009), was recently shown to 
induce apoptosis (Zikri et al. 2009).  Furthermore, a reduction in intracellular 
bacteria was observed which may, in part, be due to reduced expression of β1 
integrin.  LPva did not directly exhibit or elicit antimicrobial responses and also did 
not affect binding of type 1 fimbriae. These findings collectively suggest that LPva 
treatment promotes exfoliation of superficial bladder cells and protects the 
uroepithelium from bacterial invasion. 
 
Apoptosis is a beneficial host response which removes UPEC from the urinary tract 
due to exfoliation of apoptotic cells into the urine (Mulvey et al. 1998). We 
demonstrate that LPva induced apoptosis of BECs, with and without UPEC 
infection. This finding also indicates that LPva exerts cell protection under the 
condition of infection. Interestingly, Annexin-V staining of cell culture medium 
revealed detached apoptotic LPva-treated cells which mimics in vivo exfoliation of 
dead cells and removal in the urine. Elevated levels of caveolin-1 have been 
proposed as a marker of apoptosis in macrophages (Gargalovic and Dory 2003) 
and have furthermore been shown to ‘sensitize’ T24 BECs to other apoptosis-
inducing stimuli (Liu et al. 2001). Type 1 fimbriae, one such kind of stimuli, induce 
apoptosis-like exfoliation upon attachment to the uroepithelium (Mulvey et al. 
1998).  In the present model, we suggest that UPEC infection further induced 
apoptosis in cells already sensitized to such stimulus by LPva treatment.  
 
A significant reduction in intracellular bacteria in LPva-treated cells likely reflects 
LPva- and UPEC-induced apoptosis and exfoliation of dead infected BECs.  
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Nevertheless, decreased expression of invasion-mediating β1 integrin (Eto et al. 
2007) may also play a role. A downregulation of expression of β1 integrin mRNA 
could not be confirmed on the protein level in the current study. However, this is 
likely due to the high stability of the protein (Lindberg et al. 2010). Thus, we 
cannot rule out that at later time points, reduced levels of β1 integrin protein would 
occur. Based on our findings, we suggest that following LPva-induced apoptosis 
and consequent exfoliation of dead cells, decreased expression of β1 integrin may 
thus protect deeper layers of the uroepithelium from UPEC invasion.  
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6. Concluding remarks and future perspectives 
 
The major findings 
 
Paper I – The study provides evidence that LPva exerts uterotrophic effect and 
regulates body weight gain at least partly by modulating secretion of leptin and 
resistin, and expression of the adipokines in adipose tissues. 
 
Paper II - The study confirms that estrogen deficiency induced by ovariectomy in 
rats results in an excessive increase in Hsd11b1 gene expression which can be 
reversed by LPva treatment.  Although LPva plays a significant role in the 
regulations of Hsd11b1, it is unclear whether this effect is primary or secondary to 
changes in body composition. 
 
Paper III - The study indicates that LPva increases uterine weight, indicating 
estrogenic effects, and improves insulin sensitivity and lipid profile in PCOS rats 
without affecting body composition. 
 
Paper IV – We demonstrate that LPva has potential therapeutic applications 
against UTI. Our finding of reduced UPEC invasion of bladder epithelial cells 
following LPva treatment is likely due to LPva-induced apoptosis and possible 
down regulation of β1 integrin. This study provides new insight into the 
mechanisms of action of LPva which may help to reduce the burden of UTI faced 
by women. 
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Future perspectives 
 
The results published in this thesis are useful to improve our 
understanding of LPva actions. In spite of the limitations for each study 
design, we were reasonably able in showing LPva biological activities 
through different mechanisms via modulation of gene expression levels. 
However, they inevitably lead to further questions and debate. 
 
We have shown that LPva exerts its effects to some extent mimicking 
estrogen mode of actions. In some aspects, LPva and ERT did not show 
similar effects, mainly due to a collective of compounds in the extract. 
Therefore it is necessary to evaluate its refined active compounds. In this 
area, work will be done closely with phytochemistry research group. 
Also, little is known about its side effects and pharmacokinetics. 
Therefore, identifying bioactive compounds in LPva could be necessary 
to further investigate toxicology effects, especially at molecular levels.  
 
Furthermore, it would be valuable to further investigate the microarray 
analysis to obtain a comprehensive analysis of genetic profiles. 
Additional information may be mined from this to provide clues to many 
areas including the metabolic pathways involved. It is also important to 
study the metabolism of LPva in liver and its effect on kidney in future 
studies. It would be a great interest to carry out clinical trials among 
women in Malaysia and perform the endocrinological analyses and 
molecular studies. 
 
Nevertheless, current and future investigations will contribute to bridge 
the traditional knowledge of LPva with scientific evidence. 
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